KIMBERLY MANZONE: Open Payments
NPI 1467654525 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 10 payments from 7 companies in 2025. Trend: 2023 $603 · 2024 $290 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Viatris Specialty LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $16 |
Products named: YUPELRI, GARDASIL 9, BREZTRI, Cologuard Collection Kit, ZEPBOUND, SHINGRIX, MOUNJARO, Ozempic.
Industry payments across MA — which companies pay providers there.
